Prospective, single center , assessing the effectiveness of analgesia by continuous perineural catheter to Ropivacaine in patients hospitalized with necrotizing angiodermatitis [Etude prospective, monocentrique, évaluant l'efficacité de l'antalgie par cathéter périnerveux continu à la Ropivacaïne, chez des patients hospitalisés pour angiodermite nécrosante]

Trial Profile

Prospective, single center , assessing the effectiveness of analgesia by continuous perineural catheter to Ropivacaine in patients hospitalized with necrotizing angiodermatitis [Etude prospective, monocentrique, évaluant l'efficacité de l'antalgie par cathéter périnerveux continu à la Ropivacaïne, chez des patients hospitalisés pour angiodermite nécrosante]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms ANGIOCATH
  • Most Recent Events

    • 09 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top